Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
15 participants
OBSERVATIONAL
2021-06-09
2022-02-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Behavioral Therapy for Paranoia in Schizophrenia
NCT01704833
Fear Extinction and Mechanisms of Change in Obsessive Compulsive Disorder
NCT02467374
Psychotherapy Outcome and Self-selection Effects in Panic Disorder
NCT01606592
The Street Smart Group: A Feasibility Trial of a Group Intervention Targeting Anxiety Processes in Paranoia
NCT02408198
Face Your Fears: Cognitive Behavioural Virtual Reality Therapy for "Paranoia".
NCT04902066
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Qualitative interview
Participants will be interviewed about their experiences of recovery from paranoia.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants should have had experiences of paranoia in the context of non-affective psychosis. This will be determined by participant's agreement that they previously had the sort of thoughts listed in the revised Green et al. Paranoid Thoughts Scale (R-GPTS; Freeman, 2019);
* Participant is currently a patient of Oxford Health NHS Foundation Trust;
* Participant is willing and able to give informed consent for participation in the study;
* Aged 16 years or above;
* Participant has sufficient English language skills to participate in the interview.
Exclusion Criteria
* Diagnosis of a moderate to severe intellectual disability;
* High levels of associated risk to self or to others e.g. actively suicidal;
* Primary diagnosis of alcohol or drug misuse; personality disorder; significant forensic history;
* At the time of recruitment COVID-19 restrictions do not permit face-to-face interviews and the participant is not willing or able to conduct the interview remotely via video call.
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oxford
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr Felicity Waite, DClinPsy, BSc (Hons)
Role: STUDY_DIRECTOR
University of Oxford
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oxford Health NHS Foundation Trust
Oxford, Oxfordshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HRA
Identifier Type: OTHER
Identifier Source: secondary_id
IRAS
Identifier Type: OTHER
Identifier Source: secondary_id
PID 15402
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.